Rationality of Antidiabetic in Outpatient with Type 2 Diabetes Mellitus at PKU Muhammadiyah Yogyakarta Hospital, Special Region of Yogyakarta - Indonesia
Abstract
In the past few decades, the number of people with diabetes mellitus has steadily increased in various countries. Type 2 Diabetes Mellitus (DM) is the most common type of DM. An increase follows this significant increase in the number of patients in the use of antidiabetic drugs and the risk of irrational drug use, where drug use evaluation is one of the strategies to reduce it. This study aims to evaluate the rational use of antidiabetics in outpatients with type 2 DM at PKU Muhammadiyah Yogyakarta Hospital, Special Region of Yogyakarta - Indonesia. This study is a retrospective analytical observational study. The data used as reference is patient medical records from October 2021 to March 2022. Antidiabetic accuracy based on Indonesian Endocrinology Society guidelines and Drug Information Handbook ed. 22. A total of 155 medical records patients were included in this study. The result showed that patients with complications (50,4%) were higher than patients without complications (49,6%), with the most complication was nephropathy (67,9%) and the most comorbidity was hypertension (21,2%). The rationality of antidiabetics includes the right patient (94%), the right medicine (74%), the right dosage (100%), the right time administration (100%), and the right interval administration (97%). The rational drug use is expected to reduce the risk of drug side effects, reduce patient treatment costs, and improve patient life quality.
Keywords
Full Text:
PDFReferences
International Diabetes Federation (IDF). IDF Diabetes Atlas 8 ed. 2017. https://diabetesatlas.org/ (Accessed on 27 Juli 2021)
Ministry of Health of the Republic of IndonesiaI, 2018. Jakarta: Ministry of Health of the Republic of Indonesia. 2018
Pavlov, R., Topličan, I. Vrcić K.M. Ten-Year Trends in the Morbidity of Diabetes Mellitus and Antidiabetic Drug Utilization in Croatia: A Study Based on Routinely Collected Data. International Journal of Family Medicine. 2016:1–9
AL-Musawe, L., Martis A.P., Raposo, J.F., Torre, C., The association between polypharmacy and adverse health consequences in elderly type 2 diabetes mellitus patients; a systematic review and meta-analysis. Diabetes Research and Clinical Practice. 2019
Al-Wahibi, M., Balkhi, B., Alhawwasi, T.M., Alkofide, H., Alduhaim, N., Aladulali, R., Drweesh, H., Sambamoorthi, U. Open Access Research Polypharmacy among patients with diabetes: a cross-sectional retrospective study in a tertiary hospital in Saudi Arabia. British Medical Journal Open. 2018
Suwendar., Fitrianingsih, S. P. Analisis Rasionalitas Penggunaan Obat Diabetes Melitus Tipe 2 Pada Pasien Rawat Jalan di Rumah Sakit Muhammadiyah Bandung. Prosiding Farmasi. 2020. 6(2)
Surmelioglu N, Kiroglu O, Erdogdu T. Measures for prevention of irrational drug use. Archives of Medical Research. 2015.24(4):452–462.
Liza., Laraswati, Komplikasi Dan Komorbid Pada Pasien Diabetik Ketoasidosis (skripsi). Surabaya :Hang Tuah University; 2020.
Urgilés., Elvira, R., Minchala., Alexandra, J., Pastuña, T., Ángeles, M., González, E., Azucena, L., Sacoto, R., Ramírez, C., Andrés. Type 2 Diabetes Mellitus and Chronic Complications. International Journal of Innovative Science and Research Technology. 2020. 5(5)
Fatimah, R. Diabetes Melitus Tipe 2 Restyana. Indonesian Journal Of Pharmacy. 2015. 4(5), 93–101
Cenci., Silva., Gomes., Pinheir. Balance Analysis in Diabetic Patients Using the F-Scan System and the Berg Balance Scale. Fisioterapia em Movimento. 2017. 26(1):55-61
Ansari, P., Hannan, Shofiul, A., Jakaria. Review Challenges In Diabetic Micro Complication Management: Focus On Diabetic Neuropathy. International Journal of Translational Medicine. 2021.1, 175–186
Azhar, M. N., Suwendar., Fitrianingsih, S. P. Analisis Rasionalitas Penggunaan Obat Diabetes Melitus Tipe 2 Pada Pasien Rawat Jalan Di Rumah Sakit Muhammadiyah Bandung. Prosiding Farmasi SPeSIA. 2020
Ohsugi, M. Comorbidities And Complications In Japanese Patients With Type 2 Diabetes Mellitus: Retrospective Analyses Of J-Dreams, An Advanced Electronic Medical Records Database. Diabetes Research And Clinical Practice. 2021. 178
Yamazaki, D., Hirofumi, H., Akira, N. Hypertension With Diabetes Mellitus Complications. Hypertension Research. 2018
Kardela, W., Rahmad. A., Garmi, H. Rasionalitas Penggunaan Obat Diabetes Mellitus Tipe 2 Komplikasi Nefropati Di Rumah Sakit Umum Pusat Dr. M.Djamil Padang. Jurnal Farmasi Higea. 2019
Bonzidar, V., Tamara T, Željka C-O, Gordana, Đ., Sanjin. Diabetic Nephropathy. Intech Open Science. 2012
Azmi, S., Ioannis N. P., Maryam, F., Georgios, P., Uazman, A., Rayaz A.M. An update on the diagnosis and treatment of diabetic somatic and autonomic neuropathy. F1000 Research Faculty Reviews. 2019
Florentina, D., Rasmala Dewi, Sutrisno, D. Profil Penggunaan Antibiotik Pada Pasien Pediatri Rawat Inap Di Bangsal Anak Dengan Diagnosis Bronkopneumonia Di RSUD Raden Mattaher Jambi Periode 2017-2018. Jurnal Of Pharmacy And Science. 2021
Kurniawati,D., Anis, P.R., Fauzia, N.P., Titian, D.M., Evaluasi profil penggunaan obat antidiabetes pada pasien diabetes melitus tipe 2 rawat jalan disalah satu rumah sakit kabupaten Bogor. Journal Of Science Technology And Enterpreneurship. 2021. 3(1)
Suryanita, M. A. Pola Peresepan Obat Antidiabetes Mellitus Tipe II Pada Pasien Geriatri. Journal Of Pharmaceutical Science And Herbal. 2020. 5(1), 23–27
Monthly Index of Medical Specialities (MIMS). Amoxicillin. www.mims.com. 2021. (Accessed 1 Agustus 2022)
Kidney Disease Improving Global Outcomes (KDIGO). Kdigo Clinical Practice Guideline On Diabetes Mangement In Chronic Kidney Disease. Kidney International. 2013
Drug Information Handbook (DIH). LEXICOMP. https://online.lexi.com/lco/action/home . 2014. (accessed 1 Agustus 2022)
Indonesian Society of Endocrinology. Pedoman Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 Dewasa di Indonesia 2021. PB PERKENI. 2021
Ionnidis. Diabetes Treatment In Patients With Renal Disease: Is The Landscape Clear Enough. World Journal of Diabetes. 2014. 15:5(5): 651-658
Wulandari, Y. Evaluasi Rasionalitas Penggunaan Obat Antidiabetik Pada Pasien Diabetes Melitus Tipe 2 Rawat Jalan (Skripsi). Yogyakarta:Universitas Jendral Achmad Yani. 2021
Indonesian Society of Endocrinology. Pedoman Terapi Insulin pada Pasien Diabetes Mellitus. PERKENI. 2019
Hongdiyanto. Evaluasi Kerasionalan Pengobatan Diabetes Melitus Tipe 2 Pada Pasien Rawat Inap Di RSUP Prof. Dr. R. D. Kandou Manado Tahun. Jurnal Ilmiah Farmasi. 2014. 3(2)
Ramdini, D.A., Lilik, K.W., Dwi, A. Evaluasi Rasionalitas Penggunaan Obat Diabetes Melitus Tipe 2 Pada Pasien Rawat Jalan Di Puskesmas Pasir Sakti Tahun 2019. Jurnal Farmasi Lampung. 2020
Sa’idah, D., Sugihantoro, H., Hakim, A., Maimunah, S. Evaluasi Rasionalitas Penggunaan Obat Antihipertensi Di Instalasi Rawat Jalan RSUD Dr. Soegiri Lamongan Periode Tahun 2017. Jurnal Ilmu Kefarmasian Indonesia. 17(1). 2019
Almasdy, D., Dita, P.S, Suhatri, S., Deswinar, D., Nina, K. Evaluasi dPenggunaan Obat Antidiabetik Pada Pasien Diabetes Melitus Tipe-2 Di Suatu Rumah Sakit Pemerintah Kota Padang – Sumatera Barat. Jurnal Sains Farmasi & Klinis. 2015. 2:104
Slattery, S. A. Amiel, P. Choudhary. Optimal Prandial Timing Of Bolus Insulin In Diabetes Management: A Review. Diabetic Medicine. 2017
DOI: https://doi.org/10.15416/pcpr.v8i2.41494
Refbacks
- There are currently no refbacks.
